Giuseppe Ermondi1, Giulia Caron, Raelene Lawrence
1Dipartimento di Scienza e Tecnologia del Farmaco, V.P. Giuria 9, 1-10125 Torino, Italy. giuseppe.ermondi@unito.it
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
New computational tools enhance understanding of selective COX-2 inhibitors, like rofecoxib, for safer NSAIDs. This research clarifies interactions between cyclooxygenase-2 (COX-2) and nonsteroidal anti-inflammatory drugs (NSAIDs).
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: